Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
43,004,578
-
Share change
-
+61,065
-
Total reported value
-
$7,714,135,399
-
Put/Call ratio
-
53%
-
Price per share
-
$179.41
-
Number of holders
-
392
-
Value change
-
+$18,696,460
-
Number of buys
-
159
-
Number of sells
-
190
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2021
As of 30 Jun 2021 UNITED THERAPEUTICS Corp - Common Stock (UTHR) had 392 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,004,578 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Avoro Capital Advisors LLC, FMR LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, and Palo Alto Investors LP.
This table shows 395 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.